Maximizing the use of scarce resources: vial optimization. [electronic resource]
- Rheumatology (Oxford, England) Mar 2006
- 353-4 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1462-0324
10.1093/rheumatology/kei234 doi
Antibodies, Monoclonal--economics Antirheumatic Agents--economics Cost Control--methods Drug Costs--statistics & numerical data England Health Resources Humans Infliximab Rheumatic Diseases--drug therapy